Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Non Operating Income (2016 - 2025)

Xtant Medical Holdings has reported Non Operating Income over the past 16 years, most recently at -$976000.0 for Q3 2025.

  • Quarterly Non Operating Income rose 17.64% to -$976000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Sep 2025, up 83.55% year-over-year, with the annual reading at $33000.0 for FY2024, 32.65% down from the prior year.
  • Non Operating Income was -$976000.0 for Q3 2025 at Xtant Medical Holdings, down from $7000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $10.3 million in Q3 2023 and troughed at -$9.0 million in Q4 2023.
  • The 5-year median for Non Operating Income is -$464000.0 (2022), against an average of -$394315.8.
  • Year-over-year, Non Operating Income tumbled 35800.0% in 2022 and then soared 2444.55% in 2023.
  • A 5-year view of Non Operating Income shows it stood at -$466000.0 in 2021, then grew by 0.43% to -$464000.0 in 2022, then crashed by 1837.93% to -$9.0 million in 2023, then soared by 100.43% to $39000.0 in 2024, then crashed by 2602.56% to -$976000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Non Operating Income are -$976000.0 (Q3 2025), $7000.0 (Q2 2025), and -$1.0 million (Q1 2025).